官方服务：
资源简介：
Sputum bacterial communities determined before and after treatment with Ivacaftor
应用场景：
创建时间：
2019-06-01
相关数据集
Supplementary Material – ECZTRA 5 Manuscript
Supplementary Information to accompany and support the manuscript: Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults
Mendeley Data2024-03-27 更新210
DOM FIGURE S1 Supplementary data for studies in Figure 3.
A,B. Body weights of the 1-wk study (Fig. 3A-D). C. Body weights for the 4-week and 8-week study (Fig. 3E-L). D. Liver gene expression of 1-wk treatment with PF-04991532. E-G. Plasma insulin of drug t
DataCite Commons2020-06-25 更新70
Changes in body weight in the different groups (*p < 0.05).
D0: start of the treatment. D7: 8th day of treatment. D15: 16th day of treatment. D21: 22h day of treatment. D29: 30th day of treatment. Changes in body weight in the different groups (*p < 0.05).
NIAID Data Ecosystem30
Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials
As the pandemic of obesity presents an increasing serious health challenge worldwide, additional medical interventions, especially pharmacotherapy, should be addressed for the affected people. Liraglu
DataCite Commons2024-02-16 更新90
Second-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102
Interventions: experimental group:HR0708035, FU/LV and BP102 Primary outcome(s): Objective response rate Study Design: Single arm
NIAID Data Ecosystem40
